In lymph node-negative basal-like breast cancer, elevated tumor cell-intrinsic CTLA4 expression paradoxically correlates with excellent prognosis by inducing T-cell exhaustion and establishing an immunosuppressive microenvironment that restricts tumor progression, challenging conventional views on checkpoint inhibitors as purely therapeutic targets [15]. The gene discussed is CTLA4; the disease is neoplasm.